The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design
Abstract
A brief overview is given of platinum anticancer drugs in routine clinical use and under clinical development worldwide. Details of the binding of these drugs with nucleic acids, the preferred binding site, etc. are discussed as well. Using the mechanistic knowledge at the molecular level, in particular DNA binding, possibilities for new drugs are explored. A major part of the review deals with design, synthesis and biochemical/biophysical studies of such new compounds and their possible applications as cytostatic drugs. Special attention is given to the application of bifunctionality in such new compounds. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Self-citationAntitumour metal compounds: more than theme and variations
Jakupec, M. A., Galanski, M. S., Arion, V. B., Hartinger, C. G., & Keppler, B. K. (2008) · Dalton Transactions · doi:10.1039/b712656p · Cited by 850
Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?
Reedijk, J. (1999) · Chemical Reviews · doi:10.1021/cr980422f · Cited by 771
Self-citationNew clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
Reedijk, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737293100 · Cited by 617
Self-citationFeazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Improved understanding in platinium antitumour chemistry
Reedijk, J. (1996) · Chemical Communications · doi:10.1039/cc9960000801 · Cited by 589
Self-citationBasis for recognition of cisplatin-modified DNA by high-mobility-group proteins
Ohndorf, U.-M., Rould, M. A., He, Q., Pabo, C. O., & Lippard, S. J. (1999) · Nature · doi:10.1038/21460 · Cited by 565
The Discovery and Development of Cisplatin
Alderden, R. A., Hall, M. D., & Hambley, T. W. (2006) · Journal of Chemical Education · doi:10.1021/ed083p728 · Cited by 532
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
Hall, M. D., Okabe, M., Shen, D.-W., Liang, X.-J., & Gottesman, M. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.080907.180426 · Cited by 474
Fuertes, M., Castilla, J., Alonso, C., & Pérez, J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368484 · Cited by 432
Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 431
Multiplicity of metal ion binding patterns to nucleobases
Lippert, B. (2000) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(00)00260-5 · Cited by 430
Crystal Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA
Takahara, P. M., Frederick, C. A., & Lippard, S. J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9625079 · Cited by 405
Samimi, G., Safaei, R., Katano, K., Holzer, A. K., Rochdi, M., Tomioka, M., Goodman, M., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0137 · Cited by 358
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
Hambley, T. W. (1997) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(97)00023-4 · Cited by 348
Ang, W. H., Khalaila, I., Allardyce, C. S., Juillerat-Jeanneret, L., & Dyson, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0432618 · Cited by 314
Reedijk, B. J. (2008) · Platinum Metals Review · doi:10.1595/147106708x255987 · Cited by 312
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
Eastman, A., & Schulte, N. (1988) · Biochemistry · doi:10.1021/bi00413a022 · Cited by 312
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
Zutphen, S. V., & Reedijk, J. (2005) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2005.03.005 · Cited by 295
Self-citationThe roles of copper transporters in cisplatin resistance
Kuo, M. T., Chen, H. H. W., Song, I.-S., Savaraj, N., & Ishikawa, T. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9045-3 · Cited by 283
The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds
Reedijk, J. (1992) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)92433-2 · Cited by 247
Self-citationLovejoy, K. S., Todd, R. C., Zhang, S., McCormick, M. S., D'Aquino, J. A., Reardon, J. T., Sancar, A., Giacomini, K. M., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803441105 · Cited by 238
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
Yang, D., van Boom, S. S. G. E., Reedijk, J., van Boom, J. H., & Wang, A. H.-J. (1995) · Biochemistry · doi:10.1021/bi00039a054 · Cited by 225
Self-citationSpingler, B., Whittington, D. A., & Lippard, S. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010790t · Cited by 207
Ueber die Einwirkung des Ammoniaks auf Platinchlorür
Peyrone, M. (1844) · Justus Liebigs Annalen der Chemie · doi:10.1002/jlac.18440510102 · Cited by 168
Rice, J. A., Crothers, D. M., Pinto, A. L., & Lippard, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4158 · Cited by 168
Role of copper transporters in the uptake and efflux of platinum containing drugs
Safaei, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.046 · Cited by 160
Roy, S., Hagen, K. D., Maheswari, P. U., Lutz, M., Spek, A. L., Reedijk, J., & van Wezel, G. P. (2008) · ChemMedChem · doi:10.1002/cmdc.200800097 · Cited by 140
Self-citationKalayda, G. V., Wagner, C. H., Buß, I., Reedijk, J., & Jaehde, U. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-175 · Cited by 120
Self-citationPratesi, G., Perego, P., Polizzi, D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690620 · Cited by 118
Katano, K., Safaei, R., Samimi, G., Holzer, A. K., Tomioka, M., Goodman, M., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0689 · Cited by 104
Cisplatin Damage: Are DNA Repair Proteins Saviors or Traitors to the Cell?
Zorbas, H., & Keppler, B. K. (2005) · ChemBioChem · doi:10.1002/cbic.200400427 · Cited by 103
Knipp, M., Karotki, A. V., Chesnov, S., Natile, G., Sadler, P. J., Brabec, V., & Vašák, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070271l · Cited by 85
Cruet-Hennequart, S., Glynn, M. T., Murillo, L. S., Coyne, S., & Carty, M. P. (2008) · DNA repair · doi:10.1016/j.dnarep.2007.12.012 · Cited by 79
RNA Polymerase II Blockage by Cisplatin-damaged DNA
Jung, Y., & Lippard, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509688200 · Cited by 71
Conformation of DNA GG Intrastrand Cross-Link of Antitumor Oxaliplatin and Its Enantiomeric Analog
Malina, J., Nováková, O., Vojtı́šková, M., Natile, G., & Brabec, V. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.116996 · Cited by 70
Cisplatin Complexes with Phosphatidylserine in Membranes
Speelmans, G., Staffhorst, R. W. H. M., Versluis, K., et al. (1997) · Biochemistry · doi:10.1021/bi9703047 · Cited by 69
The First Solid-Phase Synthesis of a Peptide-Tethered Platinum(II) Complex
Robillard, M. S., Valentijn, A. R. P. M., Meeuwenoord, N. J., MAREL, G. A. V. D., BOOM, J. H. V., & Reedijk, J. (2000) · Angewandte Chemie International Edition · Cited by 67
Self-citationYang, D., van Boom, S. S. G. E., Reedijk, J., BOOM, J. H. V., Farrell, N. P., & Wang, A. H. ‐. (1995) · Nature Structural Biology · doi:10.1038/nsb0795-577 · Cited by 66
Self-citationTélétchéa, S., Komeda, S., Teuben, J., Elizondo-Riojas, M.-Á., Reedijk, J., & Kozelka, J. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200500923 · Cited by 56
Self-citationCebrián-Losantos, B., Reisner, E., Kowol, C. R., Roller, A., Shova, S. G., Arion, V. B., & Keppler, B. K. (2008) · Inorganic Chemistry · doi:10.1021/ic800506g · Cited by 52
Marqués‐Gallego, P., den Dulk, H., Brouwer, J., Kooijman, H., Spek, A. L., Roubeau, O., Teat, S. J., & Reedijk, J. (2008) · Inorganic Chemistry · doi:10.1021/ic8014767 · Cited by 51
Self-citationKalayda, G. V., Jansen, B. A. J., Wielaard, P., Tanke, H. J., & Reedijk, J. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0643-7 · Cited by 44
Self-citationKabolizadeh, P., Ryan, J., & Farrell, N. P. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.016 · Cited by 37
DNA cleavage and binding selectivity of a heterodinuclear Pt–Cu(3-Clip-Phen) complex
de Hoog, P., Pitié, M., Amadei, G. A., Gámez, P., Meunier, B., Robert Kiss, A., & Reedijk, J. (2008) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-008-0346-y · Cited by 34
Self-citationde Hoog, P., Louwerse, M. J., Gámez, P., Pitié, M., Baerends, E. J., Meunier, B., & Reedijk, J. (2007) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200701052 · Cited by 24
Self-citation
Cited by
Banerjee, S., Veale, E. B., Phelan, C. M., Murphy, S. A., Tocci, G. M., Gillespie, L. J., Frimannsson, D. O., Kelly, J. M., & Gunnlaugsson, T. (2013) · Chemical Society Reviews · doi:10.1039/c2cs35467e · Cited by 688
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Wilson, J. J., & Lippard, S. J. (2014) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 630
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
Metadata
- Authors
- Reedijk, J.
- Venue
- European Journal of Inorganic Chemistry
- Publisher
- Wiley
- Published
- 2009-03-23
- Volume
- 2009
- Issue
- 10
- Pages
- 1303-1312
- ISSN
- 1099-0682 (ISSN-L)
- 1434-1948
- OpenAlex
- W1997213816
- Cited by
- 343
- References
- 56
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.